City

Seattle (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

University of Washington (1)

Collaborator

GlaxoSmithKline (1)

Intervention

dostarlimab (1)

niraparib (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

unresectable fallopian tube carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting

Anatomic Stage III Breast Cancer AJCC v8
+51 more

Dostarlimab
Niraparib

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Mar 15, 2022